Illumina Inc. Stock Falls Friday, Underperforms Market

enVVeno Medical Corp

Change company Symbol lookup

Select an option...

NVNO enVVeno Medical Corp

MTBC CareCloud Inc

WRK Westrock Co

SNDX Syndax Pharmaceuticals Inc

SLAMU Slam Corp

SURYY Sumitomo Realty & Development Co Ltd

MKKGY Merck KGaA

DAC Danaos Corp

YY JOYY Inc

MGU Macquarie Global Infrastructure Total Return Fund Inc.

Health Care : Health Care Equipment & Supplies | Small Cap Growth

Company profile

enVVeno Medical Corporation is a med-tech company. The Company is focused on improving the standard of care in the treatment of venous disease. The Company is focused on developing tissue-based solutions that are designed for patients with chronic venous insufficiency (CVI). Its lead product, VenoValve, is a porcine based device being developed to surgically implanted in the deep venous system of the leg to treat severe CVI, including the potential to heal recurring venous leg ulcers. The VenoValve is designed to be implanted into the femoral vein of the patient in an open surgical procedure via a five-to-six-inch incision in the upper thigh. The VenoValve is being evaluated in the surgical anti-reflux venous valve endoprosthesis (SAVVE) United States clinical trial. In addition to the VenoValve, the Company is focused on the development of a second device, enVVe, for the treatment of venous disease.

Illumina Inc. Stock Falls Friday, Underperforms Market

5:01 pm ET January 21, 2022 (MarketWatch) Print

This article was automatically generated by MarketWatch using technology from Automated Insights.

Shares of Illumina Inc. (ILMN) slid 3.81% to $365.94 Friday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index falling 1.89% to 4,397.94 and Dow Jones Industrial Average falling 1.30% to 34,265.37. This was the stock's second consecutive day of losses. Illumina Inc. closed $189.83 below its 52-week high ($555.77), which the company reached on February 12th.

The stock underperformed when compared to some of its competitors Friday, as Thermo Fisher Scientific Inc. (TMO) fell 1.33% to $580.33, Danaher Corp. (DHR) fell 0.89% to $280.45, and Agilent Technologies Inc. (A) fell 1.41% to $137.51. Trading volume (1.1 M) eclipsed its 50-day average volume of 1.0 M.

Data source: Dow Jones Market Data, FactSet. Data compiled Janurary 21, 2022.

-MarketWatch Automation

(END) Dow Jones Newswires

January 21, 2022 17:01 ET (22:01 GMT)